Tomi Suomi
Medical Bioinformatics Centre tomi.suomi@utu.fi +358 29 450 3803 Tykistökatu 6 Turku ORCID identifier: https://orcid.org/0000-0003-3639-979X |
Publications
- Adaptive sequence alignment for metagenomic data analysis (2025)
- Computers in Biology and MedicineAnalytical Chemistry
(A1 Refereed original research article in a scientific journal) - CellRomeR: an R package for clustering cell migration phenotypes from microscopy data (2025)
- Bioinformatics Advances
(A1 Refereed original research article in a scientific journal) - Longitudinal pathway analysis using structural information with case studies in early type 1 diabetesTargeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory (2025)
- Scientific ReportsDiabetologia
(A1 Refereed original research article in a scientific journal) - Metaproteomics Beyond Databases: Addressing the Challenges and Potentials of De Novo SequencingBenchmarking tools for detecting longitudinal differential expression in proteomics data allows establishing a robust reproducibility optimization regression approach (2025)
- ProteomicsNature Communications
(B1 Other refereed article (e.g., editorial, letter, comment) in a scientific journal) - Proteomic profiling reveals alterations in metabolic and cellular pathways in severe obesity and following metabolic bariatric surgeryComputational solutions for spatial transcriptomics (2025)
- American Journal of Physiology : Endocrinology and Metabolism
(A1 Refereed original research article in a scientific journal) - Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease (2025)
- DiabetologiaComputational and Structural Biotechnology Journal
(A1 Refereed original research article in a scientific journal) - Disruption of HSD17B12 in mouse hepatocytes leads to reduced body weight and defect in the lipid droplet expansion associated with microvesicular steatosisCOVID-19-specific transcriptomic signature detectable in blood across multiple cohorts (2024)
- FASEB JournalFrontiers in Genetics
(A1 Refereed original research article in a scientific journal) - Distinct cellular immune responses in children en route to type 1 diabetes with different first-appearing autoantibodies (2024)
- Nature Communications
(A1 Refereed original research article in a scientific journal) - ECCB2024: The 23rd European Conference on Computational Biology (2024)
- Bioinformatics
(B1 Non-refereed article in a scientific journal) - Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes : An INNODIA multicenter study (2024)
- Diabetes/Metabolism Research and Reviews
(A1 Refereed original research article in a scientific journal) - Phenotypic profiling of human induced regulatory T cells at early differentiation : insights into distinct immunosuppressive potential (2024)
- Cellular and Molecular Life Sciences
(A1 Refereed original research article in a scientific journal) - Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk (2024)
- iScience
(A1 Refereed original research article in a scientific journal) - The Proteomics Standards Initiative Standardized Formats for Spectral Libraries and Fragment Ion Peak Annotations: mzSpecLib and mzPAF (2024)
(A1 Refereed original research article in a scientific journal) - Gene expression signature predicts rate of type 1 diabetes progression (2023)
- EBioMedicine
(A1 Refereed original research article in a scientific journal) - Profiling of peripheral blood B-cell transcriptome in children who developed coeliac disease in a prospective study (2023)
- Heliyon
(A1 Refereed original research article in a scientific journal) - 2023
(A1 Refereed original research article in a scientific journal) - (2022)
(A1 Refereed original research article in a scientific journal) - (2022)
(A2 Refereed review article in a scientific journal ) - (2022)
(A1 Refereed original research article in a scientific journal) - Improved risk prediction of chemotherapy-induced neutropenia-model development and validation with real-world data (2022)
- Cancer Medicine
(A1 Refereed original research article in a scientific journal)